A Study of RG-012 in Subjects With Alport Syndrome
Clinical trial NCT03373786 · COMPLETED
Trial details
- NCT number
- NCT03373786
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-22
- Primary completion
- 2019-05-20
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.